It's obviously early stage, but I'd absolutely love to see the Canadian Blood Service invest in lots of follow up studies to see how we can scale this technology.
Also, it's always great to see my alma mater on HN :)
It's obviously early stage, but I'd absolutely love to see the Canadian Blood Service invest in lots of follow up studies to see how we can scale this technology.
Also, it's always great to see my alma mater on HN :)
Type O- is rare because being rhesus-negative is rare, but type O+ is quite common.
Rhesus negative had the problem of birth issues when their mothers had born rhesus positive elder siblings sadly.
[0] https://en.m.wikipedia.org/wiki/Hemolytic_disease_of_the_new...
Are there any advantages of using blood with the patient's specific antigen type over plain O-negative? Perhaps keeping all blood types available might still be a good idea in a hospital setting.
And there are lots of other less important blood factors. In most situations the donor blood is cross matched with the patient's blood, to directly test compatibility.
https://www.healthline.com/health/blood-typing-and-crossmatc...